{"count":308,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=kratom&page=2&page_size=25","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/49296a22-5f9f-4077-821c-0bf31955bddf/","filing_uuid":"49296a22-5f9f-4077-821c-0bf31955bddf","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/49296a22-5f9f-4077-821c-0bf31955bddf/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark W. Rodgers","dt_posted":"2016-09-19T12:20:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/49296a22-5f9f-4077-821c-0bf31955bddf/","filing_uuid":"49296a22-5f9f-4077-821c-0bf31955bddf","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/49296a22-5f9f-4077-821c-0bf31955bddf/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark W. Rodgers","dt_posted":"2016-09-19T12:20:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/49296a22-5f9f-4077-821c-0bf31955bddf/","filing_uuid":"49296a22-5f9f-4077-821c-0bf31955bddf","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/49296a22-5f9f-4077-821c-0bf31955bddf/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark W. Rodgers","dt_posted":"2016-09-19T12:20:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":true},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8901b776-ed46-4d3d-a598-b59db8dd4b21/","filing_uuid":"8901b776-ed46-4d3d-a598-b59db8dd4b21","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8901b776-ed46-4d3d-a598-b59db8dd4b21/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2016-09-21T15:38:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8901b776-ed46-4d3d-a598-b59db8dd4b21/","filing_uuid":"8901b776-ed46-4d3d-a598-b59db8dd4b21","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8901b776-ed46-4d3d-a598-b59db8dd4b21/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2016-09-21T15:38:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8901b776-ed46-4d3d-a598-b59db8dd4b21/","filing_uuid":"8901b776-ed46-4d3d-a598-b59db8dd4b21","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8901b776-ed46-4d3d-a598-b59db8dd4b21/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2016-09-21T15:38:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Senator Orrin Hatch ; Principal ; Prinicpal","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b4081172-ae33-4214-8514-bd0dbccb6734/","filing_uuid":"b4081172-ae33-4214-8514-bd0dbccb6734","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/b4081172-ae33-4214-8514-bd0dbccb6734/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2016-10-13T10:01:39.917000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b4081172-ae33-4214-8514-bd0dbccb6734/","filing_uuid":"b4081172-ae33-4214-8514-bd0dbccb6734","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/b4081172-ae33-4214-8514-bd0dbccb6734/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2016-10-13T10:01:39.917000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b4081172-ae33-4214-8514-bd0dbccb6734/","filing_uuid":"b4081172-ae33-4214-8514-bd0dbccb6734","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/b4081172-ae33-4214-8514-bd0dbccb6734/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2016-10-13T10:01:39.917000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c93e66cb-7caf-4b40-8e02-6a49faa1930f/","filing_uuid":"c93e66cb-7caf-4b40-8e02-6a49faa1930f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/c93e66cb-7caf-4b40-8e02-6a49faa1930f/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CLAUDIA VALENTE","dt_posted":"2016-10-13T16:25:07.397000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c93e66cb-7caf-4b40-8e02-6a49faa1930f/","filing_uuid":"c93e66cb-7caf-4b40-8e02-6a49faa1930f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/c93e66cb-7caf-4b40-8e02-6a49faa1930f/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CLAUDIA VALENTE","dt_posted":"2016-10-13T16:25:07.397000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c93e66cb-7caf-4b40-8e02-6a49faa1930f/","filing_uuid":"c93e66cb-7caf-4b40-8e02-6a49faa1930f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/c93e66cb-7caf-4b40-8e02-6a49faa1930f/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CLAUDIA VALENTE","dt_posted":"2016-10-13T16:25:07.397000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/9b200858-ba39-4066-b446-cb8e919f71b1/","filing_uuid":"9b200858-ba39-4066-b446-cb8e919f71b1","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/9b200858-ba39-4066-b446-cb8e919f71b1/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"LAWRENCE LOFTIN FLOWERS","dt_posted":"2016-10-20T23:03:53.377000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"535 WEST 116TH STREET","registrant_address_2":"302 LOW LIBRARY","registrant_different_address":false,"registrant_city":"NEW YORK","registrant_state":"NY","registrant_zip":"10027","registrant":{"id":38585,"url":"https://lda.gov/api/v1/registrants/38585/","house_registrant_id":30887,"name":"THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK","description":"Higher Education","address_1":"535 WEST 116TH STREET","address_2":"302 LOW LIBRARY","address_3":null,"address_4":null,"city":"NEW YORK","state":"NY","state_display":"New York","zip":"10027","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAWRENCE LOFTIN FLOWERS","contact_telephone":"+1 212-854-3738","dt_updated":"2026-07-28T13:46:15.827577-04:00"},"client":{"id":146805,"url":"https://lda.gov/api/v1/clients/146805/","client_id":12,"name":"TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5393, Commerce, Justice, Science, and Related Agencies Appropriations for FY17.\nS. 2837, Commerce, Justice, Science, and Related Agencies Appropriations for FY17.\nS. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations for FY17.\nHouse Draft Legislation: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations for FY17.\nH.R.5325, Continuing Appropriations Act, 2017.\nMonitor funding for the National Science Foundation and the National Institutes of Health.\nCongressional outreach related to funding for the National Science Foundation and the National Institutes of Health.\nH.R. 2289, Commodity End-User Relief Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48112,"prefix":"mr","prefix_display":"MR.","first_name":"LAWRENCE","nickname":null,"middle_name":"LOFTIN","last_name":"FLOWERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45546,"prefix":"mr","prefix_display":"MR.","first_name":"ROSS","nickname":null,"middle_name":"A","last_name":"FROMMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Monitor administrative and legislative action related to Title VI Education Funding and International Education Funding.\nCongressional outreach related to Title VI Education Funding and International Education Funding.\nMonitor administrative and legislative action related to federal student aid and Pell grants.\nMonitor administrative and legislative action related to campus planning.\nS. 1374, Foreign Medical School Fairness Act.\nDepartment of Education Proposed Rule on Borrower Defense to Repayment. [Docket ID ED-2015-OPE-0103]","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48112,"prefix":"mr","prefix_display":"MR.","first_name":"LAWRENCE","nickname":null,"middle_name":"LOFTIN","last_name":"FLOWERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45546,"prefix":"mr","prefix_display":"MR.","first_name":"ROSS","nickname":null,"middle_name":"A","last_name":"FROMMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor legislative and administrative action related to Student Health Insurance Plans under the Affordable Care Act.\nCongressional outreach related to Student Health Insurance Plans.\nCongressional outreach related to the Drug Enforcement Administration's Notice of Intent to temporarily place kratom into Schedule I of the Controlled Substances Act. [Docket No. DEA-442]\nMonitor legislative action related to mental health reform.\nS. 2680, Mental Health Reform Act of 2016.\nH.R. 2646, Helping Families in Mental Health Crisis Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45546,"prefix":"mr","prefix_display":"MR.","first_name":"ROSS","nickname":null,"middle_name":"A","last_name":"FROMMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/bc5e90e3-b8da-4df3-be44-e9d1fe689f36/","filing_uuid":"bc5e90e3-b8da-4df3-be44-e9d1fe689f36","filing_type":"3A","filing_type_display":"3rd Quarter - Amendment","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/bc5e90e3-b8da-4df3-be44-e9d1fe689f36/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"LAWRENCE LOFTIN FLOWERS","dt_posted":"2016-10-25T11:58:05.793000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"535 WEST 116TH STREET","registrant_address_2":"302 LOW LIBRARY","registrant_different_address":false,"registrant_city":"NEW YORK","registrant_state":"NY","registrant_zip":"10027","registrant":{"id":38585,"url":"https://lda.gov/api/v1/registrants/38585/","house_registrant_id":30887,"name":"THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK","description":"Higher Education","address_1":"535 WEST 116TH STREET","address_2":"302 LOW LIBRARY","address_3":null,"address_4":null,"city":"NEW YORK","state":"NY","state_display":"New York","zip":"10027","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAWRENCE LOFTIN FLOWERS","contact_telephone":"+1 212-854-3738","dt_updated":"2026-07-28T13:46:15.827577-04:00"},"client":{"id":146805,"url":"https://lda.gov/api/v1/clients/146805/","client_id":12,"name":"TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor legislative and administrative action related to Student Health Insurance Plans under the Affordable Care Act.\nCongressional outreach related to Student Health Insurance Plans.\nCongressional outreach related to the Drug Enforcement Administration's Notice of Intent to temporarily place kratom into Schedule I of the Controlled Substances Act. [Docket No. DEA-442]\nMonitor legislative action related to mental health reform.\nS. 2680, Mental Health Reform Act of 2016.\nH.R. 2646, Helping Families in Mental Health Crisis Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45546,"prefix":"mr","prefix_display":"MR.","first_name":"ROSS","nickname":null,"middle_name":"A","last_name":"FROMMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5393, Commerce, Justice, Science, and Related Agencies Appropriations for FY17.\nS. 2837, Commerce, Justice, Science, and Related Agencies Appropriations for FY17.\nS. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations for FY17.\nHouse Draft Legislation: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations for FY17.\nH.R.5325, Continuing Appropriations Act, 2017.\nMonitor funding for the National Science Foundation and the National Institutes of Health.\nCongressional outreach related to funding for the National Science Foundation and the National Institutes of Health.\nH.R. 2289, Commodity End-User Relief Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48112,"prefix":"mr","prefix_display":"MR.","first_name":"LAWRENCE","nickname":null,"middle_name":"LOFTIN","last_name":"FLOWERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45546,"prefix":"mr","prefix_display":"MR.","first_name":"ROSS","nickname":null,"middle_name":"A","last_name":"FROMMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Monitor administrative and legislative action related to Title VI Education Funding and International Education Funding.\nCongressional outreach related to Title VI Education Funding and International Education Funding.\nMonitor administrative and legislative action related to federal student aid and Pell grants.\nMonitor administrative and legislative action related to campus planning.\nS. 1374, Foreign Medical School Fairness Act.\nDepartment of Education Proposed Rule on Borrower Defense to Repayment. [Docket ID ED-2015-OPE-0103]","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48112,"prefix":"mr","prefix_display":"MR.","first_name":"LAWRENCE","nickname":null,"middle_name":"LOFTIN","last_name":"FLOWERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45546,"prefix":"mr","prefix_display":"MR.","first_name":"ROSS","nickname":null,"middle_name":"A","last_name":"FROMMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/646b5d00-3aba-4d88-8d40-adbabc7cae69/","filing_uuid":"646b5d00-3aba-4d88-8d40-adbabc7cae69","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/646b5d00-3aba-4d88-8d40-adbabc7cae69/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-01-12T12:32:38-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/646b5d00-3aba-4d88-8d40-adbabc7cae69/","filing_uuid":"646b5d00-3aba-4d88-8d40-adbabc7cae69","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/646b5d00-3aba-4d88-8d40-adbabc7cae69/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-01-12T12:32:38-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/646b5d00-3aba-4d88-8d40-adbabc7cae69/","filing_uuid":"646b5d00-3aba-4d88-8d40-adbabc7cae69","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/646b5d00-3aba-4d88-8d40-adbabc7cae69/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-01-12T12:32:38-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/32dfc974-11bc-42c0-aa66-56341431bbd6/","filing_uuid":"32dfc974-11bc-42c0-aa66-56341431bbd6","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/32dfc974-11bc-42c0-aa66-56341431bbd6/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CLAUDIA BARKER VALENTE","dt_posted":"2017-01-18T17:09:18-05:00","termination_date":"2016-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/32dfc974-11bc-42c0-aa66-56341431bbd6/","filing_uuid":"32dfc974-11bc-42c0-aa66-56341431bbd6","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/32dfc974-11bc-42c0-aa66-56341431bbd6/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CLAUDIA BARKER VALENTE","dt_posted":"2017-01-18T17:09:18-05:00","termination_date":"2016-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/32dfc974-11bc-42c0-aa66-56341431bbd6/","filing_uuid":"32dfc974-11bc-42c0-aa66-56341431bbd6","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/32dfc974-11bc-42c0-aa66-56341431bbd6/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CLAUDIA BARKER VALENTE","dt_posted":"2017-01-18T17:09:18-05:00","termination_date":"2016-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"HAMILTON SQUARE - 5TH FLOOR","registrant_address_2":"600 14TH STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":45983,"url":"https://lda.gov/api/v1/registrants/45983/","house_registrant_id":34337,"name":"VALENTE & ASSOCIATES","description":"A Government Affairs Firm","address_1":"HAMILTON SQUARE - 5TH FLOOR","address_2":"600 14TH STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK VALENTE III","contact_telephone":"+1 703-354-9082","dt_updated":"2022-04-06T16:08:10.107338-04:00"},"client":{"id":153863,"url":"https://lda.gov/api/v1/clients/153863/","client_id":1026,"name":"THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)","general_description":"A Government Affairs Firm","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"In opposition to DEA's classification of Kratom as a Schedule I controlled substance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42427,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"WILLIAM","last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":"Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.","new":false},{"lobbyist":{"id":62120,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"DANIEL","last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner","new":false},{"lobbyist":{"id":65260,"prefix":null,"prefix_display":null,"first_name":"CLAUDIA","nickname":null,"middle_name":"BARKER","last_name":"VALENTE","suffix":null,"suffix_display":null},"covered_position":"Special Asst. to the Comptroller, U.S. DoD","new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3b5473d5-a3af-4f82-846e-a74c638d360e/","filing_uuid":"3b5473d5-a3af-4f82-846e-a74c638d360e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2017,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3b5473d5-a3af-4f82-846e-a74c638d360e/print/","filing_document_content_type":"text/html","income":"67000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-07-05T14:37:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3b5473d5-a3af-4f82-846e-a74c638d360e/","filing_uuid":"3b5473d5-a3af-4f82-846e-a74c638d360e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2017,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3b5473d5-a3af-4f82-846e-a74c638d360e/print/","filing_document_content_type":"text/html","income":"67000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-07-05T14:37:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/460140c2-3b3c-43ff-b0ad-8e3177bcb9b8/","filing_uuid":"460140c2-3b3c-43ff-b0ad-8e3177bcb9b8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2017,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/460140c2-3b3c-43ff-b0ad-8e3177bcb9b8/print/","filing_document_content_type":"text/html","income":"67000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-10-19T08:29:02.660000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/460140c2-3b3c-43ff-b0ad-8e3177bcb9b8/","filing_uuid":"460140c2-3b3c-43ff-b0ad-8e3177bcb9b8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2017,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/460140c2-3b3c-43ff-b0ad-8e3177bcb9b8/print/","filing_document_content_type":"text/html","income":"67000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-10-19T08:29:02.660000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/36bc21ee-2151-4cad-9e7e-bef1813faa58/","filing_uuid":"36bc21ee-2151-4cad-9e7e-bef1813faa58","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2017,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/36bc21ee-2151-4cad-9e7e-bef1813faa58/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John M. Haddow","dt_posted":"2017-11-17T14:35:07-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":88278,"url":"https://lda.gov/api/v1/registrants/88278/","house_registrant_id":36652,"name":"UPSTREAM CONSULTING","description":"Government Relations","address_1":"P.O. Box 159","address_2":null,"address_3":null,"address_4":null,"city":"Catharpin","state":"VA","state_display":"Virginia","zip":"20143","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"C. MCCLAIN HADDOW","contact_telephone":"+1 571-294-5978","dt_updated":"2026-07-20T11:58:47.764743-04:00"},"client":{"id":173904,"url":"https://lda.gov/api/v1/clients/173904/","client_id":568,"name":"AMERICAN KRATOM ASSOCIATION","general_description":"​protect the right of all Americans to use the natural botanical Kratom for improved healt","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"overturn DEA restrictions on Kratom","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64518,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68662,"prefix":null,"prefix_display":null,"first_name":"MCCLAIN","nickname":null,"middle_name":"C","last_name":"HADDOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}